Atlas Trials

The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19

Clinical trial NCT04468139 · UNKNOWN

Trial details

NCT number
NCT04468139
Sponsor
Ministry of Health, Saudi Arabia
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Covid-19
Start date
2020-06-20
Primary completion
2020-07-20
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.